This report provides an overview of the US molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
  1. Health Care Expenditures
  2. Cost Consciousness
  3. Reimbursement
  4. Industry Consolidation
  5. Managed Care
      a. PPO
      b. HMO
  6. Hospitals
  7. Admissions
  8. Length of Stay
  9. Industry Diversification
10. Physician Demographics
11. Population Aging
      a. Chronic Illness
      b. Disease Incidence
      c. Susceptibility to Iatrogenesis
      d. Multiple Illness Cases
12. Laboratory Regulations
13. FDA Reform

Market Structure
  1. Hospitals
  2. Commercial/Private Laboratories
  3. Blood Banks
 
Market Size, Growth, and Major Suppliers' Market Shares
               
List of Tables

Molecular Diagnostics Test Volume Forecasts by Application

Molecular Diagnostic Sales Forecasts by Application

Market Shares of Major Supplier of Molecular Diagnostic Tests  

Market Shares of Major Supplier of HIV/Hepatitis Blood Screening Assays

Market Shares of Major Supplier of West Nile Virus Blood Screening Assays

Contains 42 pages and 5 tables